Stock BINV BIOINVENT INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BioInvent International AB

Equities

BINV

SE0015244520

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:36 2024-06-07 am EDT 		5-day change 1st Jan Change
35.1 SEK +4.93% Intraday chart for BioInvent International AB -5.01% +85.13%
May. 23 BioInvent Presents Promising Phase 1 Data for Bi-1206 in Combination with KEYTRUDA (Pembrolizumab) in Patients with Solid Tumors CI
May. 23 BioInvent International AB Presents Promising Clinical Efficacy and Safety for Anti-Tnfr2 Agent BI-1808 At Asco 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOINVENT INTERNATIONAL AB Stock BioInvent International AB
 219M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. BINV Stock
  4. Charts BioInvent International AB
  5. Sector Chart